Response Rate After Modified Regime DHAP and Toxicity with Refractory and Relapsed Disease in Lymphoma Patients. Life and Science, [S. l.], v. 4, n. 4, p. 7, 2023. DOI: 10.37185/LnS.1.1.348. Disponível em: https://www.lifenscience.org/index.php/life-and-science/article/view/348. Acesso em: 18 oct. 2026.